Coskun U - Search Results

1

Serum P-selectin, soluble vascular cell adhesion molecule-I (s-VCAM-I) and soluble intercellular adhesion molecule-I (s-ICAM-I) levels in bladder carcinoma patients with different stages.

Coskun U, Sancak B, Sen I, Bukan N, Tufan MA, Gülbahar O, Sozen S. Coskun U, et al. Int Immunopharmacol. 2006 Apr;6(4):672-7. doi: 10.1016/j.intimp.2005.10.009. Epub 2005 Nov 28. Int Immunopharmacol. 2006. PMID: 16504931

2

Serum interleukin-18 and nitric oxide activity in bladder carcinoma.

Bukan N, Sözen S, Coskun U, Sancak B, Günel N, Bozkirli I, Senocak C. Bukan N, et al. Among authors: coskun u. Eur Cytokine Netw. 2003 Jul-Sep;14(3):163-7. Eur Cytokine Netw. 2003. PMID: 14656691 Free article.

3

Serum big endothelin-1 levels in female patients with breast cancer.

Yildirim Y, Gunel N, Coskun U, Sancak B, Bukan N, Aslan S, Cetin A. Yildirim Y, et al. Among authors: coskun u. Int Immunopharmacol. 2008 Aug;8(8):1119-23. doi: 10.1016/j.intimp.2008.03.023. Epub 2008 Apr 28. Int Immunopharmacol. 2008. PMID: 18550016

4

Elevated serum levels of M30 and M65 in patients with locally advanced head and neck tumors.

Ozturk B, Coskun U, Sancak B, Yaman E, Buyukberber S, Benekli M. Ozturk B, et al. Among authors: coskun u. Int Immunopharmacol. 2009 May;9(5):645-8. doi: 10.1016/j.intimp.2009.02.004. Epub 2009 Feb 26. Int Immunopharmacol. 2009. PMID: 19249390

5

Serum M30 levels are associated with survival in advanced gastric carcinoma patients.

Yaman E, Coskun U, Sancak B, Buyukberber S, Ozturk B, Benekli M. Yaman E, et al. Among authors: coskun u. Int Immunopharmacol. 2010 Jul;10(7):719-22. doi: 10.1016/j.intimp.2010.03.013. Epub 2010 Mar 31. Int Immunopharmacol. 2010. PMID: 20362077

6

Serum levels of interleukin-18 and nitrite+nitrate in renal cell carcinoma patients with different tumor stage and grade.

Sözen S, Coskun U, Sancak B, Bukan N, Günel N, Tunc L, Bozkirli I. Sözen S, et al. Among authors: coskun u. Neoplasma. 2004;51(1):25-9. Neoplasma. 2004. PMID: 15004655

7

Serum YKL-40 levels as a prognostic factor in patients with locally advanced breast cancer.

Yamac D, Ozturk B, Coskun U, Tekin E, Sancak B, Yildiz R, Atalay C. Yamac D, et al. Among authors: coskun u. Adv Ther. 2008 Aug;25(8):801-9. doi: 10.1007/s12325-008-0082-2. Adv Ther. 2008. PMID: 18670741

8

Serum and Ascitic Fluid Superoxide Dismutase and Malondialdehyde Levels in Patients with Cirrhosis.

Ozenirler S, Sancak B, Coskun U. Ozenirler S, et al. Among authors: coskun u. Biomark Insights. 2008 Mar 12;3:141-145. doi: 10.4137/bmi.s639. Biomark Insights. 2008. PMID: 19578501 Free PMC article.

9

Increased serum granulocyte colony stimulating factor in Turkish hepatocellular carcinoma patients.

Kaya AO, Coskun U, Sancak B, Buyukberber S, Yildiz R, Gulbahar O, Benekli M, Ozenirler S. Kaya AO, et al. Among authors: coskun u. Asian Pac J Cancer Prev. 2009 Jul-Sep;10(3):403-6. Asian Pac J Cancer Prev. 2009. PMID: 19640182 Free article.

10

No association between serum levels of insulin-like growth factor-I, vascular endothelial growth factor, prolactin and clinicopathological characteristics of breast carcinoma after surgery.

Sancak B, Coskun U, Gunel N, Onuk E, Cihan A, Karamercan A, Yildirim Y, Ozkan S. Sancak B, et al. Among authors: coskun u. Intern Med J. 2004 Jun;34(6):310-5. doi: 10.1111/j.1444-0903.2004.00591.x. Intern Med J. 2004. PMID: 15228391

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

298 results

Search Page

Filters